Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 9 (2023)

Response of silkworm (Bombyx mori L.) hybrid (CSR2 x CSR4) to topical application of juvenile hormone analogue (Methoprene)

Author(s):
Asif Rafiq Rather, Nisar A Ganie, KA Dar, Farhat Iqbal Qadir, Munazah Yaqoob, SA Mir and Imtiyaz Murtaza
Abstract:
Juvenile hormone analogues (JHA) are recognized for their ability to extend the larval stage in insects. These compounds have been observed to enhance both the qualitative and quantitative characteristics of the silkworm Bombyx mori L. In our current investigation, we applied the juvenile hormone analogue known as methoprene topically to a popular bivoltine hybrid of silkworms (CSR2 x CSR4) at different concentrations (0.01 µl, 0.1 µl, 1 µl per larva) at various time points (24, 48, 72, and 96 hours after the start of the fifth instar stage). This treatment combination resulted in a significant increase in the weight of individual cocoons, the weight of the cocoon shells and shell percentage. The most substantial improvement was observed in the silkworm groups treated with 0.1 µl of methoprene per larva 48 hours into the fifth instar. The incorporation of juvenile hormone analogue (Methoprene) into Sericultural practices holds promise for achieving higher quality and quantity of silk cocoons.
Pages: 613-615  |  224 Views  129 Downloads


The Pharma Innovation Journal
How to cite this article:
Asif Rafiq Rather, Nisar A Ganie, KA Dar, Farhat Iqbal Qadir, Munazah Yaqoob, SA Mir, Imtiyaz Murtaza. Response of silkworm (Bombyx mori L.) hybrid (CSR2 x CSR4) to topical application of juvenile hormone analogue (Methoprene). Pharma Innovation 2023;12(9):613-615.

Call for book chapter